Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Lymphoma|Advanced Solid Tumors
Interventions: DRUG: E7766
Sponsor: Eisai Inc.
Collaborators: H3 Biomedicine Inc.